Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice

Chad Hall, Laurent Ehrlich, Fanyin Meng, Pietro Invernizzi, Francesca Bernuzzi, Terry C. Lairmore, Gianfranco Alpini, Shannon Glaser

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Liver transplantation remains the primary treatment for primary sclerosing cholangitis (PSC). Mdr2-/- mice provide a reliable in vivo model of PSC and develop characteristic biliary inflammation and fibrosis. We tested the hypothesis that the tumor suppressor protein menin is implicated in the progression of liver fibrosis and that menin expression can be regulated in the liver via microRNA-24 (miR-24). Materials and methods: Menin expression was measured in human PSC and Mdr2-/- mice. Twelve-week-old FVB/NJ wild-type (WT) and Mdr2-/- mice were treated with miR-24 Vivo-Morpholino to knockdown miR-24 expression levels. Liver fibrosis was evaluated by Sirius Red staining and quantitative polymerase chain reaction (qPCR) for genes associated with liver fibrosis, such as fibronectin 1, collagen type 1 alpha 1, transforming growth factor-β1 (TGF-β1), and α-smooth muscle actin. Studies were also performed in vitro using immortalized murine cholangiocyte lines treated with miR-24 hairpin inhibitor and mimic. Results: Menin gene expression was increased in Mdr2-/- mice and late-stage human PSC samples. Treatment of FVB/NJ WT and Mdr2-/- mice with miR-24 Vivo-Morpholino increased menin expression, which correlated with increased expression of fibrosis genes. In vitro, inhibition of miR-24 also significantly increased the expression of fibrosis genes. Conclusions: Inhibition of miR-24 increases menin and TGF-β1 expression, subsequently increasing hepatic fibrosis in FVB/NJ WT and Mdr2-/- mice. Modulation of the menin/miR-24 axis may provide novel targeted therapies to slow the progression of hepatic fibrosis into cirrhosis in PSC patients by altering TGF-β1 expression.

Original languageEnglish (US)
JournalJournal of Surgical Research
DOIs
StateAccepted/In press - Feb 2 2017

Fingerprint

MicroRNAs
Liver Cirrhosis
Sclerosing Cholangitis
Fibrosis
Morpholinos
Transforming Growth Factors
Gene Expression
Liver
Tumor Suppressor Proteins
Transforming Growth Factor alpha
Collagen Type I
Fibronectins
Liver Transplantation
Smooth Muscle
Actins
Therapeutics
Staining and Labeling
Inflammation
Polymerase Chain Reaction
Genes

Keywords

  • Hepatic fibrosis
  • Liver
  • Menin
  • MiR-24

ASJC Scopus subject areas

  • Surgery

Cite this

Hall, C., Ehrlich, L., Meng, F., Invernizzi, P., Bernuzzi, F., Lairmore, T. C., ... Glaser, S. (Accepted/In press). Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2017.05.020

Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice. / Hall, Chad; Ehrlich, Laurent; Meng, Fanyin; Invernizzi, Pietro; Bernuzzi, Francesca; Lairmore, Terry C.; Alpini, Gianfranco; Glaser, Shannon.

In: Journal of Surgical Research, 02.02.2017.

Research output: Contribution to journalArticle

Hall, Chad ; Ehrlich, Laurent ; Meng, Fanyin ; Invernizzi, Pietro ; Bernuzzi, Francesca ; Lairmore, Terry C. ; Alpini, Gianfranco ; Glaser, Shannon. / Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice. In: Journal of Surgical Research. 2017.
@article{7f0949bb954e47068ae9e4ed310c1975,
title = "Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice",
abstract = "Background: Liver transplantation remains the primary treatment for primary sclerosing cholangitis (PSC). Mdr2-/- mice provide a reliable in vivo model of PSC and develop characteristic biliary inflammation and fibrosis. We tested the hypothesis that the tumor suppressor protein menin is implicated in the progression of liver fibrosis and that menin expression can be regulated in the liver via microRNA-24 (miR-24). Materials and methods: Menin expression was measured in human PSC and Mdr2-/- mice. Twelve-week-old FVB/NJ wild-type (WT) and Mdr2-/- mice were treated with miR-24 Vivo-Morpholino to knockdown miR-24 expression levels. Liver fibrosis was evaluated by Sirius Red staining and quantitative polymerase chain reaction (qPCR) for genes associated with liver fibrosis, such as fibronectin 1, collagen type 1 alpha 1, transforming growth factor-β1 (TGF-β1), and α-smooth muscle actin. Studies were also performed in vitro using immortalized murine cholangiocyte lines treated with miR-24 hairpin inhibitor and mimic. Results: Menin gene expression was increased in Mdr2-/- mice and late-stage human PSC samples. Treatment of FVB/NJ WT and Mdr2-/- mice with miR-24 Vivo-Morpholino increased menin expression, which correlated with increased expression of fibrosis genes. In vitro, inhibition of miR-24 also significantly increased the expression of fibrosis genes. Conclusions: Inhibition of miR-24 increases menin and TGF-β1 expression, subsequently increasing hepatic fibrosis in FVB/NJ WT and Mdr2-/- mice. Modulation of the menin/miR-24 axis may provide novel targeted therapies to slow the progression of hepatic fibrosis into cirrhosis in PSC patients by altering TGF-β1 expression.",
keywords = "Hepatic fibrosis, Liver, Menin, MiR-24",
author = "Chad Hall and Laurent Ehrlich and Fanyin Meng and Pietro Invernizzi and Francesca Bernuzzi and Lairmore, {Terry C.} and Gianfranco Alpini and Shannon Glaser",
year = "2017",
month = "2",
day = "2",
doi = "10.1016/j.jss.2017.05.020",
language = "English (US)",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice

AU - Hall, Chad

AU - Ehrlich, Laurent

AU - Meng, Fanyin

AU - Invernizzi, Pietro

AU - Bernuzzi, Francesca

AU - Lairmore, Terry C.

AU - Alpini, Gianfranco

AU - Glaser, Shannon

PY - 2017/2/2

Y1 - 2017/2/2

N2 - Background: Liver transplantation remains the primary treatment for primary sclerosing cholangitis (PSC). Mdr2-/- mice provide a reliable in vivo model of PSC and develop characteristic biliary inflammation and fibrosis. We tested the hypothesis that the tumor suppressor protein menin is implicated in the progression of liver fibrosis and that menin expression can be regulated in the liver via microRNA-24 (miR-24). Materials and methods: Menin expression was measured in human PSC and Mdr2-/- mice. Twelve-week-old FVB/NJ wild-type (WT) and Mdr2-/- mice were treated with miR-24 Vivo-Morpholino to knockdown miR-24 expression levels. Liver fibrosis was evaluated by Sirius Red staining and quantitative polymerase chain reaction (qPCR) for genes associated with liver fibrosis, such as fibronectin 1, collagen type 1 alpha 1, transforming growth factor-β1 (TGF-β1), and α-smooth muscle actin. Studies were also performed in vitro using immortalized murine cholangiocyte lines treated with miR-24 hairpin inhibitor and mimic. Results: Menin gene expression was increased in Mdr2-/- mice and late-stage human PSC samples. Treatment of FVB/NJ WT and Mdr2-/- mice with miR-24 Vivo-Morpholino increased menin expression, which correlated with increased expression of fibrosis genes. In vitro, inhibition of miR-24 also significantly increased the expression of fibrosis genes. Conclusions: Inhibition of miR-24 increases menin and TGF-β1 expression, subsequently increasing hepatic fibrosis in FVB/NJ WT and Mdr2-/- mice. Modulation of the menin/miR-24 axis may provide novel targeted therapies to slow the progression of hepatic fibrosis into cirrhosis in PSC patients by altering TGF-β1 expression.

AB - Background: Liver transplantation remains the primary treatment for primary sclerosing cholangitis (PSC). Mdr2-/- mice provide a reliable in vivo model of PSC and develop characteristic biliary inflammation and fibrosis. We tested the hypothesis that the tumor suppressor protein menin is implicated in the progression of liver fibrosis and that menin expression can be regulated in the liver via microRNA-24 (miR-24). Materials and methods: Menin expression was measured in human PSC and Mdr2-/- mice. Twelve-week-old FVB/NJ wild-type (WT) and Mdr2-/- mice were treated with miR-24 Vivo-Morpholino to knockdown miR-24 expression levels. Liver fibrosis was evaluated by Sirius Red staining and quantitative polymerase chain reaction (qPCR) for genes associated with liver fibrosis, such as fibronectin 1, collagen type 1 alpha 1, transforming growth factor-β1 (TGF-β1), and α-smooth muscle actin. Studies were also performed in vitro using immortalized murine cholangiocyte lines treated with miR-24 hairpin inhibitor and mimic. Results: Menin gene expression was increased in Mdr2-/- mice and late-stage human PSC samples. Treatment of FVB/NJ WT and Mdr2-/- mice with miR-24 Vivo-Morpholino increased menin expression, which correlated with increased expression of fibrosis genes. In vitro, inhibition of miR-24 also significantly increased the expression of fibrosis genes. Conclusions: Inhibition of miR-24 increases menin and TGF-β1 expression, subsequently increasing hepatic fibrosis in FVB/NJ WT and Mdr2-/- mice. Modulation of the menin/miR-24 axis may provide novel targeted therapies to slow the progression of hepatic fibrosis into cirrhosis in PSC patients by altering TGF-β1 expression.

KW - Hepatic fibrosis

KW - Liver

KW - Menin

KW - MiR-24

UR - http://www.scopus.com/inward/record.url?scp=85020266648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020266648&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2017.05.020

DO - 10.1016/j.jss.2017.05.020

M3 - Article

C2 - 28602220

AN - SCOPUS:85020266648

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

ER -